Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Sobi files MAA to expand Kineret label

Nov. 20, 2012

Pluristem begins phase I/II trial of PLX cells in muscle injury

Nov. 20, 2012

Incyte and Lilly present promising phase II data for baricitinib in rheumatoid arthritis

Nov. 20, 2012

Incyte earns milestone payment from Lilly

Nov. 19, 2012

TissueGene completes enrollment in phase II study of TG-C

Nov. 16, 2012

Brodalumab does not demonstrate meaningful clinical efficacy in patients with RA

Nov. 15, 2012

U.S. screening begins for new phase Ib study of PRTX-100

Nov. 13, 2012

Promising phase I results reported for subcutaneous MOR-103

Nov. 12, 2012

Clinical benefit of GLPG-0634 in rheumatoid arthritis confirmed in phase IIa trial

Nov. 9, 2012

Auxilium and Pfizer to terminate European agreement for Xiapex

Nov. 9, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...